WHWK (Whitehawk Therapeutics) Accounts Payable: $1.75 Mil (As of Mar. 2026)


WHWK Whitehawk Therapeutics Inc WHWK
38 GF Score
Price $4.17
GF Value $0.27
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Whitehawk Therapeutics Accounts Payable?

Whitehawk Therapeutics WHWK +3.23% 38 Accounts Payable is $1.75 Mil as of Mar. 2026. GuruFocus rates WHWK with a GF Score™ of 38/100 and a GF Value™ of $0.27 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Whitehawk Therapeutics's Accounts Payable for the quarter that ended in Mar. 2026 was $1.75 Mil.

Whitehawk Therapeutics's quarterly Accounts Payable declined from Sep. 2025 ($1.63 Mil) to Dec. 2025 ($0.92 Mil) but then increased from Dec. 2025 ($0.92 Mil) to Mar. 2026 ($1.75 Mil).

Whitehawk Therapeutics's annual Accounts Payable declined from Dec. 2023 ($5.90 Mil) to Dec. 2024 ($2.16 Mil) and declined from Dec. 2024 ($2.16 Mil) to Dec. 2025 ($0.92 Mil).

Whitehawk Therapeutics Accounts Payable Related Terms

Whitehawk Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Whitehawk Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Whitehawk Therapeutics Accounts Payable Chart

Whitehawk Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 6.44 3.52 5.90 2.16 0.92

Whitehawk Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.66 3.34 1.63 0.92 1.75
WHWK
38GF Score
Whitehawk Therapeutics Inc WHWK
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Whitehawk Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.75 Mil mean?
Whitehawk Therapeutics (WHWK) has a Accounts Payable of $1.75 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Whitehawk Therapeutics and its competitors.
Is Whitehawk Therapeutics' Accounts Payable too high?
Whitehawk Therapeutics' current Accounts Payable is $1.75 Mil. Overall, Whitehawk Therapeutics has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Whitehawk Therapeutics' Accounts Payable compare to IMUX and TTRX?
Whitehawk Therapeutics' Accounts Payable of $1.75 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Whitehawk Therapeutics and its competitors. Whitehawk Therapeutics's current Accounts Payable is $1.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Whitehawk Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Whitehawk Therapeutics (WHWK) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.27, compared to a current price of $4.17 — trading 1444.4% above its estimated fair value. The current Accounts Payable is $1.75 Mil. Whitehawk Therapeutics' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Whitehawk Therapeutics (WHWK), the current Accounts Payable is $1.75 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Whitehawk Therapeutics (WHWK) Overvalued in 2026?

Based on GuruFocus' analysis, Whitehawk Therapeutics stock appears to be overvalued. The current stock price of $4.17 is trading 1444.4% above its estimated GF Value™ of $0.27. GuruFocus considers Whitehawk Therapeutics to be Significantly Overvalued.

Key valuation signals for WHWK:

  • Accounts Payable: $1.75 Mil
  • GF Value™: $0.27 vs. price of $4.17 (1444.4% above fair value)
  • GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the WHWK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Whitehawk Therapeutics Business Description

Other Exchanges 3350:Germany
Address 2 Headquarters Plaza East Building, 11th Floor, Morristown, New Jersey, NJ, USA, 07960
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
38GF Score

Get the complete analysis for WHWK

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.17
Price
$0.27
GF Value